Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oneinforty is a non-profit organization focused on raising awareness and providing education regarding the prevalence of BRCA gene mutations in the Ashkenazi Jewish population. The organization highlights the statistical reality that one in forty individuals of Ashkenazi descent carries a BRCA1 or BRCA2 mutation, a rate significantly higher than that of the general population. Oneinforty provides resources for genetic counseling, testing, and risk-management support to help prevent hereditary cancers such as breast, ovarian, prostate, and pancreatic cancer. Through community outreach and educational programs, the entity empowers at-risk individuals to take proactive steps in their healthcare. The organization serves as a vital link between the community and medical professionals specializing in hereditary cancer syndromes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oneinforty.